Is Pharma for Harris or Trump?
October 31, 2024
No Comments
Simon Wentworth of ThePhamaLetter.com asked, “How might the outcome of the forthcoming presidential election affect health policy in a country that represents both the largest market for pharmaceuticals, and the most important setting for drug